Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A [Phase 3]

View source ↗

Summary

Phase 3 trial to evaluate the efficacy and safety of CKD-202A in essential hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• CKD-202A

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Essential Hypertension | Phase 3 | Status: RECRUITING